Mo1045 ASSESSING HEALTHCARE ACCESS HURDLES FACED BY INDIVIDUALS WITH COLON CANCER: A NATIONAL HEALTH INTERVIEW SURVEY
Leggi →
Maggio 2024
Risultati per: Gestione dei diverticoli del colon (malattia diverticolare del colon)
Questo è quello che abbiamo trovato per te
Sa1234 TNFRSF19-MEDIATED PATHWAYS DRIVE TUMORIGENESIS IN COLON TUMOROIDS DERIVED FROM A PLAGL2 OVEREXPRESSING CRISPR/CAS9-MEDIATED MOUSE MODEL OF COLON CARCINOGENESIS
Leggi →
Maggio 2024
1084 A PILOT CLINICAL STUDY OF SELF-PROPELLED RETROGRADE TETHERED CAPSULE ENDOMICROSCOPY (R-TCE) OF THE LOWER COLON IN UNSEDATED PATIENTS
Leggi →
Maggio 2024
Sa1223 A HUMAN PRIMARY CELL MODEL OF THE INFLAMED COLON WITH UTILITY FOR IBD THERAPEUTIC DRUG DISCOVERY AND DEVELOPMENT.
Leggi →
Maggio 2024
Sa1217 IN VITRO GENERATED COLON EPITHELIAL MONOLAYER FOR STUDYING BACTERIA-IECS CROSSTALK DURING MUCOSAL INFLAMMATION IN INFLAMMATORY BOWEL DISEASE
Leggi →
Maggio 2024
1279 HIGH SUSCEPTIBILITY OF COLITIS-ASSOCIATED COLON CANCER IN NEUROPEPTIDE Y (NPY) DEFICIENT MICE
Leggi →
Maggio 2024
534 ADVANCED ADENOMA IS ASSOCIATED WITH LONG-TERM RISK OF COLORECTAL CANCER, CANCER RELATED MORTALITY AND ALL-CAUSE MORTALITY: ANALYSIS OF THE MINNESOTA COLON CANCER SCREENING TRIAL
Leggi →
Maggio 2024
393 ARTIFICIAL INTELLIGENCE ASSISTED COLONOSCOPY IMPROVES PDR AND ADR IN RIGHT COLON IN PATIENTS WITH IBD: A COHORT STUDY IN A HIGH-VOLUME CENTER
Leggi →
Maggio 2024
636 CAN BUTYRATE PREVENT COLON CANCER? THE AUSFAP STUDY: A RANDOMISED, CROSS-OVER CLINICAL TRIAL
Leggi →
Maggio 2024
Sa1713 A NIGRO−VAGAL PATHWAY CONTROLS PROXIMAL COLON MOTILITY AND IS IMPAIRED IN A RAT MODEL OF PARKINSONISM
Leggi →
Maggio 2024
576 MICROBIOTA-INDUCED S100A11-RAGE AXIS UNDERLIES IMMUNOEVASION IN RIGHT-SIDED COLON ADENOMAS AND IS A THERAPEUTIC TARGET TO BOOST ANTI-PD1 EFFICACY
Leggi →
Maggio 2024
Su1944 INTRARECTAL ADMINISTRATION OF CONJUGATED BILE ACIDS REDUCES FOOD INTAKE, REDUCES WEIGHT, AND INCREASES GLP-1 IN RODENTS AND EX VIVO HUMAN COLON
Leggi →
Maggio 2024
Su1946 CHANGES IN BOWEL MORPHOLOGY AND MOTILITY ASSESSED BY MRI IN PATIENTS WITH SHORT BOWEL SYNDROME INTESTINAL FAILURE (SBS-IF) AND COLON-IN-CONTINUITY (CIC) TREATED WITH APRAGLUTIDE
Leggi →
Maggio 2024
Su1947 PARENTERAL SUPPORT WEANING, CLINICAL BENEFIT AND IMPROVED PATIENT REPORTED OUTCOMES IN SHORT BOWEL SYNDROME INTESTINAL FAILURE (SBS-IF) PATIENTS WITH COLON-IN-CONTINUITY (CIC) TREATED WITH THE LONG-ACTING GLUCAGON-LIKE PEPTIDE-2 (GLP-2) ANALOG APRAGLUTIDE
Leggi →
Maggio 2024
Su1948 APRAGLUTIDE TREATMENT IN SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE (SBS-IF) AND COLON-IN-CONTINUITY (CIC) IS ASSOCIATED WITH INCREASED ORAL INTAKE AND IMPROVED ENERGY AND CARBOHYDRATE ABSORPTION AT 48 WEEKS
Leggi →
Maggio 2024
775 THE TELOMERE CLOCK FUNCTION IN COLON MUCOSA AND THE REASON WHY BOTH SHORT AND LONG TELOMERES ARE ASSOCIATED WITH COLORECTAL CANCER
Leggi →
Maggio 2024
